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Predominant in Nonceliac
Wheat Sensitivity Than
Celiac Disease?Dear Editor:
We read with great interest the recent paper published
by Carroccio et al reporting on the prevalence of autoim-
munity (as identiﬁed by positivity of antinuclear antibodies
[ANA] and associated autoimmune disorders) in nonceliac
wheat sensitivity (NCWS) versus celiac disease (CD) and
irritable bowel syndrome (IBS).1 More in detail, the results
of the study, based on a retrospective and prospective arm,
showed that the prevalence of ANA in NCWS was
signiﬁcantly higher than in CD and IBS (46% in NCWS vs
24% in CD and 2% in IBS, retrospectively; and 28% in
NCWS vs 7.5% in CD and 6% in IBS, prospectively).
Moreover, in both retrospective and prospective analysis,
autoimmune disorders (mainly autoimmune thyroiditis)
were found in a slightly higher proportion in NCWS (29%
vs 24%) than CD (21% vs 20%). Both NCWS and CD
showed a signiﬁcantly higher prevalence of autoimmune
disorders than IBS. ANA were signiﬁcantly related to HLA-
DQ2 and -DQ8 in NCWS (both retrospectively and pro-
spectively), whereas these autoantibodies were associated
signiﬁcantly with autoimmune disorders only in the pro-
spective arm.
Clearly, the results from Carroccio et al capture the in-
terest of the scientiﬁc community as NCWS, more than an
established autoimmune disorder, such as CD, exhibits a
surprisingly high autoimmune proﬁle. Indeed, CD is a well-
established autoimmune condition characterized by
frequent occurrence of different types of autoantibodies and
associated autoimmune disorders.2 These autoimmune
features have not been demonstrated previously in NCWS
and whether these patients are actually prone to develop
autoimmune dysfunction remains an open issue.3,4 In this
regard, recent data from our group showed that only 14%
of 486 patients with NCWS had an associated autoimmune
disorder including thyroiditis, psoriasis, Graves disease,
type 1 diabetes mellitus, and atrophic gastritis.5 In
contrast, the same autoimmune manifestations were
detected in CD patients, but with a markedly higher
prevalence (ie, about 30% of 770 CD patients) than that
reported in NCWS.6 These ﬁndings are in line with
previously published data.7
A further interesting aspect that emerged from the study
of Carroccio et al1 is the very high prevalence of ANA in
their cohort of NCWS versus CD and IBS patients. In our
experience, however, the prevalence of ANA was found to
be higher in CD than NCWS and IBS (49% vs 37% vs 6%),
which reﬂects a predominant autoimmune proﬁle in CD
rather than in the 2 other conditions. However, theevidence that patients with NCWS display a higher
expression of ANA compared with IBS is in line with the
results presented by Carroccio et al.1
In conclusion, consistent evidence supports a major role
of adaptive immunity in CD more than NCWS, and this
peculiarity is reﬂected by a predominant occurrence of
autoimmune disorders and autoantibodies (eg, ANA).8
However, the challenging data shown by Carroccio et al
provide the basis to understand whether NCWS, like CD,
exhibits a wide spectrum of autoimmune manifestations
mediated by adaptive mechanisms. Further studies are
eagerly awaited to shed light on the intriguing relationship
between autoimmunity and NCWS.
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Most current article
http://dx.doi.org/10.1053/j.gastro.2015.08.058Reply. We thank Volta et al for their interest in our
work1 and for their comments and data on the
frequency of autoimmune diseases and serumautoantibodies in patients suffering from nonceliac wheat
sensitivity (NCWS). These authoritative colleagues have
emphasized that celiac disease is a well-established auto-
immune condition, and we agree that NCWS is still an un-
deﬁned syndrome with uncertain pathogenesis.
However, the data they reported actually further
strengthen our data on a link between NCWS and autoim-
munity and contribute to suggesting a strong role for innate
and adaptive immunity in the pathogenesis of NCWS. The
authors reported that, in their experience, 37% of NCWS pa-
tients were positive for antinuclear antibodies, a percentage
clearly higher than in patients with irritable bowel syndrome
and in the middle of the frequencies we observed in our
January 2016 Correspondence 283retrospective (46%) and prospective (28%) cohorts.We think
the lower frequency of serum for antinuclear antibody posi-
tivity we found compared with the data from Volta et al is
much less relevant among our ﬁndings. We studied only a
small group of celiac disease patients as a control group, and
our study was not designed to evaluate this aspect of celiac
disease.
Regarding the frequency of autoimmune disorders asso-
ciated with NCWS, we underline that ours is the ﬁrst single-
center study designed to provide data on this point. The
discrepancy between the frequency we observed (24% vs
29%) and that reported in the Italian multicenter study
(14%)2 could be owing to the heterogeneity of the patients
included in that study. In a brilliant editorial Lebwohl and
Lefﬂer have written, “in critical moments, men sometimes
see exactly what they wish to see,”3 and it is evident that at
the moment there is no agreement in the scientiﬁc
community not only about NCWS pathogenesis, but even on
its real existence. Although relevant in many ways, the
Italian multicenter study probably suffered from the
“negative preconception” of those centers skeptical about
NCWS, a preconception that was ampliﬁed by the confuse
diagnostic criteria and the lack of a double-blind challenge
as diagnostic method.
In contrast, it is certain that NCWS should be considered
a heterogeneous condition as we ﬁrst suggested some years
ago,4 in which different kinds of patients with different
pathogenesis of their wheat-related symptoms are still
lumped together. Since the beginning of our interest in
NCWS, we have focused on the patients who had an
“immunologic characteristic”: food allergy in infancy, asso-
ciated atopic disease, eosinophil or lymphocyte inﬁltration
in the intestinal mucosa, and so on.5 Consequently, in the
Rorschach test of sorts3 we view a strong immunologic
basis for NCWS pathogenesis, but in the discussion section
we warned readers about this possible bias of a highly
selected study population.
In conclusion, we feel that the “NCWS ﬁeld” still remains
a “fertile crescent” for research6 and in this respect,
understanding the immunological path is the most
promising, as suggested by our recent data,1 especially
considering the possible role of amylase/trypsin inhibitors
as activators of innate immunity.7,8
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Nonalcoholic Steatohepatitis in
Extreme ObesityDear Editor:
The article by Lassailly et al1 reported on 1540
patients who had undergone a bariatric surgery
procedure that included 1489 cases in whom
intraoperative liver biopsies were obtained. Surprisingly,
histologic nonalcoholic steatohepatitis (NASH) was
diagnosed in only 115 of the 1489 cases (7.7%). In the
Discussion, this unusually low rate of disease is given
only sparse attention. In addressing limitations of the
study the authors state that, “the prevalence of NASH
was lower than in other studies, but this could be
explained by the absence of any selection of enrolled
patients among surgical candidates.” This is not an
adequate explanation for results that are signiﬁcantly
discrepant from other published studies of liver biopsy
data from patients with extreme obesity undergoing
bariatric surgery procedures. A review2 of such studies
found the prevalence of nonalcoholic fatty liver disease
(NAFLD) and NASH averaged 90% and 37%,
respectively, consistent with our own recent data.3
Rather than an absence of selection criteria as an
underlying cause, the results presented are more likely
highly biased owing to a lack of representative sampling
from an extremely high false-negative detection rate,
that is, many individuals from a cohort with extreme
obesity expected to manifest NASH were excluded. We
believe that sampling error from the use of needle biopsies
versus the much larger size of wedge biopsies commonly
used in other studies contributes to the disparity in the
NASH prevalence reported. Wedge biopsies have consis-
tently been shown to be superior to needle biopsies for
assessment of liver histology primarily because substan-
tially more tissue is obtained for evaluation.4,5
In addition, the lack of correction for multiple
comparisons is highly problematic and further weakens the
